102例高血压性心脏病合并心力衰竭患者的临床研究

目的：探讨美托洛尔治疗高血压性心脏并合并心力衰竭患者的临床效果。方法：回顾性分析本院2011年1月-2012年9月治疗的102例高血压性心脏病合并心力衰竭患者病例资料,所有患者按随机表法分为两组,对照组患者给予常规治疗,包括强心、硝酸甘油、利尿、吸氧等治疗措施,治疗组在此基础上给予患者应用美托洛尔进行治疗,比较两组患者治疗效果。结果：治疗后,治疗组有效率及超声心动指标均好于对照组,差异具有统计学意义（P〈0.05）;治疗后,治疗组NYHA心功能评价Ⅰ级者优于对照组,差异具有统计学意义（P〈0.05）。结论：美托洛尔药物可以改善患者的心脏功能,治疗高血压性心脏病合并心力衰竭是安全有效的,值得推广。

Analysis of 102 Cases with Hypertensive Heart Disease andHeart Failure

Objective： To investigate the effect of metoprolol for hypertensive heart disease and heart failure. Method： The data of 102 cases with hypertensive heart disease and heart failure in the hospital from January 2011 to September 2012 were retrospectively analyzed. All the patients were randomly divided into treatment group and control group. The control group was treated by conventional therapy, included cardiotonic, glyceryl trinitrate, diuresis, and oxygen uptake, and the treatment group did metoprolol on the base of the control group. Compared curative effect between the two groups. Result： After treatment, the treatment group effectiveness and ultrasonic echocardiography indexes were better than the control group, difference had statistical significance （ P〈0.05 ） ; After treatment, the treatment group I NYHA heart function evaluation level was better than that of control group, the difference had statistically significant （ P〈0.05 ） . Conclusion： The metoprolol can improve patient＇s heart function, which is safe and effective for hypertensive heart disease and heart failure.